Literature DB >> 22864807

[Compliance of patients concerning recommended radiotherapy in breast cancer : Association with recurrence, age, and hormonal therapy].

K-J Winzer1, C Gruber, H Badakhshi, M Hinkelbein, C Denkert.   

Abstract

BACKGROUND AND
PURPOSE: In this study, we investigated how often guidelines for radiation therapy in patients with breast cancer are not complied with, which patient group is mostly affected, and how this influences local recurrence. PATIENTS AND METHODS: All patients (n = 1,903) diagnosed between November 2003 and December 2008 with primary invasive or intraductal breast cancer in the interdisciplinary breast center of the Charité Hospital Berlin were included and followed for a median 2.18 years.
RESULTS: Patients who, in contrast to the recommendation of the interdisciplinary tumor board, did not undergo postoperative radiation experienced a fivefold higher local recurrence rate (p < 0.0005), corresponding to a 5-year locoregional recurrence-free survival of 74.5% in this group. The 5-year locoregional recurrence-free survival of patients following the recommendations was 93.3%. Guideline compliance was dependent on age of patients, acceptance of adjuvant hormonal treatment or chemotherapy, and increased diameter of the primary tumor. Multiple logistic regression analysis showed an association between compliance and age or hormonal therapy.
CONCLUSION: In order to avoid local recurrence patients should be motivated to comply with guideline driven therapy. Since a higher number of local recurrences is observed in health services research compared to clinical research, studies on the value of adjuvant treatment following local recurrence should be performed.

Entities:  

Mesh:

Year:  2012        PMID: 22864807     DOI: 10.1007/s00066-012-0153-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  19 in total

1.  Relationship of distance from a radiotherapy facility and initial breast cancer treatment.

Authors:  A B Nattinger; R T Kneusel; R G Hoffmann; M A Gilligan
Journal:  J Natl Cancer Inst       Date:  2001-09-05       Impact factor: 13.506

2.  Guideline-compatible treatment of breast cancer patients: the status quo in schleswig-holstein.

Authors:  Annika Waldmann; Ron Pritzkuleit; Heiner Raspe; Alexander Katalinic
Journal:  Dtsch Arztebl Int       Date:  2008-05-02       Impact factor: 5.594

3.  Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patients.

Authors:  Matthias W Beckmann; Cosima Brucker; Volker Hanf; Claudia Rauh; Mayada R Bani; Stefanie Knob; Sabrina Petsch; Stefan Schick; Peter A Fasching; Arndt Hartmann; Michael P Lux; Lothar Häberle
Journal:  Onkologie       Date:  2011-06-15

4.  Classification of CAM use and its correlates in patients with early-stage breast cancer.

Authors:  Juliann Saquib; Lisa Madlensky; Sheila Kealey; Nazmus Saquib; Loki Natarajan; Vicky A Newman; Ruth E Patterson; John P Pierce
Journal:  Integr Cancer Ther       Date:  2011-03-07       Impact factor: 3.279

5.  [Evidence-based medicine in oncology: do the results of trials reflect clinical reality?].

Authors:  D Hölzel; G Schubert-Fritschle
Journal:  Zentralbl Chir       Date:  2008-02       Impact factor: 0.942

6.  Completion of adjuvant radiation therapy among women with breast cancer.

Authors:  Tomasz P Srokowski; Shenying Fang; Zhigang Duan; Thomas A Buchholz; Gabriel N Hortobagyi; James S Goodwin; Sharon H Giordano
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

7.  Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer.

Authors:  Nicole Hébert-Croteau; Jacques Brisson; Jean Latreille; Michèle Rivard; Nadia Abdelaziz; Ginette Martin
Journal:  J Clin Oncol       Date:  2004-08-02       Impact factor: 44.544

8.  Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study.

Authors:  K Hancke; M D Denkinger; J König; C Kurzeder; A Wöckel; D Herr; M Blettner; R Kreienberg
Journal:  Ann Oncol       Date:  2009-10-13       Impact factor: 32.976

9.  Impact of guideline conformity on breast cancer therapy: results of a 13-year retrospective cohort study.

Authors:  Achim Wöckel; Dominic Varga; Ziad Atassi; Christian Kurzeder; Regine Wolters; Manfred Wischnewsky; Christine Wulff; Rolf Kreienberg
Journal:  Onkologie       Date:  2010-01-22

Review 10.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Authors:  S Darby; P McGale; C Correa; C Taylor; R Arriagada; M Clarke; D Cutter; C Davies; M Ewertz; J Godwin; R Gray; L Pierce; T Whelan; Y Wang; R Peto
Journal:  Lancet       Date:  2011-10-19       Impact factor: 79.321

View more
  2 in total

1.  Timing of radiotherapy following breast-conserving surgery: outcome of 1393 patients at a single institution.

Authors:  S Corradini; O M Niemoeller; M Niyazi; F Manapov; M Haerting; N Harbeck; C Belka; S Kahlert
Journal:  Strahlenther Onkol       Date:  2014-02-07       Impact factor: 3.621

Review 2.  When are breast cancer patients old enough for the quitclaim of local control?

Authors:  M L Sautter-Bihl; F Sedlmayer; W Budach; J Dunst; P Feyer; R Fietkau; W Haase; W Harms; C Rödel; R Souchon; F Wenz; R Sauer
Journal:  Strahlenther Onkol       Date:  2012-10-28       Impact factor: 3.621

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.